MOMENTA PHARMACEUTICALS, INC.
Corporation · WILMINGTON, United States · LEI 529900BB2VMRCT4YQ588
LEI active
Summary
MOMENTA PHARMACEUTICALS, INC. is registered in the United States. Its legal form is Corporation. According to GLEIF, its ultimate parent is Johnson & Johnson (United States), which is also its direct parent. That group has 209 subsidiaries with LEIs in 47 countries, 55 of them in the United States. The LEI was first issued on 23 Nov 2018 and the record was last updated on 15 Jul 2026; the next renewal is due by 18 Jul 2027. GLEIF's ISIN mapping lists 1 ISIN for this LEI. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2021, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | Corporation |
|---|---|
| Register | · Register website |
| Registration number | 3389038 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER, 19801 WILMINGTON, United States |
| Headquarters address | 1125 Trenton-Harbourton Road, 05860 Trenton, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 17 May 2001 |
| LEI | 529900BB2VMRCT4YQ588 |
| LEI status | active |
| LEI first issued | 23 Nov 2018 |
| LEI record last updated | 15 Jul 2026 |
| Next LEI renewal | 18 Jul 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
MOMENTA PHARMACEUTICALS, INC. this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Johnson & Johnson | Johnson & Johnson |
| Accounting period | 1 Jan 2021 to 31 Dec 2021 | 1 Jan 2021 to 31 Dec 2021 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Relationship start | 18 Nov 2022 | 18 Nov 2022 |
| Recorded at GLEIF since | 23 Nov 2018 | 23 Nov 2018 |
| Last updated | 21 Aug 2025 | 21 Aug 2025 |
| Record status | current | current |
Other subsidiaries of the same direct parent (97)
- ACCLARENT, INC. United States
- ACTELION PHARMACEUTICALS US, INC. United States lapsed
- ALZA CORPORATION United States
- AMO HOLDINGS, INC. United States lapsed
- AMO SALES AND SERVICE, INC. United States
- AURIS HEALTH, INC. United States
- BIOMEDICAL ENTERPRISES, INC. United States lapsed
- BIOSENSE WEBSTER, INC. United States
- CORDIS FINANCING CORPORATION United States lapsed
- DEPUY SYNTHES PRODUCTS, INC. United States
- DEPUY SYNTHES SALES, INC. United States
- DEPUY SYNTHES, INC. United States
ISINs mapped to this LEI (1)
US60877T1007
1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.
History
11 Aug 2021Headquarters address changed